Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy

[1]  R. van Hillegersberg,et al.  Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI , 2020, Acta oncologica.

[2]  R. van Hillegersberg,et al.  Robotic-assisted minimally invasive esophagectomy: past, present and future. , 2020, Journal of thoracic disease.

[3]  Y. Seto,et al.  Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma , 2019, International Journal of Clinical Oncology.

[4]  M. Sosef,et al.  Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  Masayuki Watanabe,et al.  Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma , 2019, Esophagus.

[6]  M. Yano,et al.  Clinical Implications of Conversion Surgery After Induction Therapy for T4b Thoracic Esophageal Squamous Cell Carcinoma , 2019, Annals of Surgical Oncology.

[7]  I. B. Borel Rinkes,et al.  Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial , 2019, Annals of surgery.

[8]  Chi Lin,et al.  Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base , 2019, American journal of clinical oncology.

[9]  Jinming Yu,et al.  The value of magnetic resonance imaging in esophageal carcinoma: Tool or toy? , 2019, Asia-Pacific journal of clinical oncology.

[10]  Y. Doki,et al.  Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review , 2018, Annals of gastroenterological surgery.

[11]  R. van Hillegersberg,et al.  Surgical robotics for esophageal cancer , 2018, Annals of the New York Academy of Sciences.

[12]  Derya Yakar,et al.  Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study , 2018, BMC Cancer.

[13]  R. van Hillegersberg,et al.  Two-Field Lymphadenectomy During Esophagectomy: The Presence of Thoracic Duct Lymph Nodes. , 2018, The Annals of thoracic surgery.

[14]  A. Egashira,et al.  Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion , 2018, Annals of Surgical Oncology.

[15]  K. Chìn,et al.  Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer , 2016, British Journal of Cancer.

[16]  R. van Hillegersberg,et al.  Internal and External Validation of a multivariable Model to Define Hospital-Acquired Pneumonia After Esophagectomy , 2016, Journal of Gastrointestinal Surgery.

[17]  E. Steyerberg,et al.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. , 2015, The Lancet. Oncology.

[18]  J. Ruurda,et al.  Robot‐assisted minimally invasive esophagectomy for esophageal cancer: A systematic review , 2015, Journal of surgical oncology.

[19]  Arnulf H Hölscher,et al.  International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). , 2015, Annals of surgery.

[20]  E. D. Geijsen,et al.  Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[21]  Y. Nishimura,et al.  Clinical results of definitive-dose (50 Gy/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancer , 2015, International Journal of Clinical Oncology.

[22]  J. Blazeby,et al.  Reporting outcomes of definitive radiation-based treatment for esophageal cancer: a review of the literature. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[23]  A. Duranceau,et al.  Endobronchial ultrasonography added to endoscopic ultrasonography improves staging in esophageal cancer. , 2013, The Annals of thoracic surgery.

[24]  H. Shimoji,et al.  Induction Chemotherapy or Chemoradiotherapy Followed by Radical Esophagectomy for T4 Esophageal Cancer: Results of a Prospective Cohort Study , 2013, World Journal of Surgery.

[25]  R. Shridhar,et al.  Outcomes Associated with Surgery for T4 Esophageal Cancer , 2013, Annals of Surgical Oncology.

[26]  R. van Hillegersberg,et al.  Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial) , 2012, Trials.

[27]  S. Roberts,et al.  Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

[28]  J. Ajani,et al.  Failure patterns in patients with esophageal cancer treated with definitive chemoradiation , 2012, Cancer.

[29]  R. van Hillegersberg,et al.  How to Define a Positive Circumferential Resection Margin in T3 Adenocarcinoma of the Esophagus , 2011, The American journal of surgical pathology.

[30]  C. Hurt,et al.  Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[31]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[32]  Y. Seto,et al.  Treatment of thoracic esophageal carcinoma invading adjacent structures , 2007, Cancer science.

[33]  T. Conroy,et al.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  F. Pasini,et al.  Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion , 2007, Journal of surgical oncology.

[35]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.

[36]  J. Petiot,et al.  Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.

[37]  H. Fujita,et al.  Esophagectomy: Is It Necessary after Chemoradiotherapy for a Locally Advanced T4 Esophageal Cancer? Prospective Nonrandomized Trial Comparing Chemoradiotherapy with Surgery versus without Surgery , 2004, World Journal of Surgery.

[38]  K. Shibuya,et al.  Correlation between endobronchial ultrasonography (EBUS) images and histologic findings in normal and tumor-invaded bronchial wall. , 2002, Lung cancer.